Non-annotated gene. Preliminary data : if you are an author who wish to write a full paper/card on this gene, contribute in submission tool
Other Information
Locus ID:
NCBI: 4246
MIM: 604398
HGNC: 7051
Ensembl: ENSG00000124939
Variants:
dbSNP: 4246
ClinVar: 4246
TCGA: ENSG00000124939
COSMIC: SCGB2A1
RNA/Proteins
| Gene ID | Transcript ID | Uniprot |
|---|---|---|
| ENSG00000124939 | ENST00000244930 | O75556 |
Expression (GTEx)
Protein levels (Protein atlas)
References
| Pubmed ID | Year | Title | Citations |
|---|---|---|---|
| 29729704 | 2018 | Detection of gene expression in sentinel lymph node of primary breast cancer patients. | 0 |
| 29729704 | 2018 | Detection of gene expression in sentinel lymph node of primary breast cancer patients. | 0 |
| 25906123 | 2016 | The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors. | 18 |
| 25906123 | 2016 | The Novel Marker GATA3 is Significantly More Sensitive Than Traditional Markers Mammaglobin and GCDFP15 for Identifying Breast Cancer in Surgical and Cytology Specimens of Metastatic and Matched Primary Tumors. | 18 |
| 25425335 | 2015 | GATA-binding protein 3, gross cystic disease fluid protein-15 and mammaglobin have distinct prognostic implications in different invasive breast carcinoma subgroups. | 3 |
| 25425335 | 2015 | GATA-binding protein 3, gross cystic disease fluid protein-15 and mammaglobin have distinct prognostic implications in different invasive breast carcinoma subgroups. | 3 |
| 24585249 | 2014 | SCGB2A1 is a novel prognostic marker for colorectal cancer associated with chemoresistance and radioresistance. | 15 |
| 24603286 | 2014 | Differential expression of secretoglobins in normal ovary and in ovarian carcinoma--overexpression of mammaglobin-1 is linked to tumor progression. | 5 |
| 24706379 | 2014 | The clinical utility of circulating tumor cells in breast cancer patients: detection by a quantitative assay of h-MAM gene expression. | 0 |
| 24585249 | 2014 | SCGB2A1 is a novel prognostic marker for colorectal cancer associated with chemoresistance and radioresistance. | 15 |
| 24603286 | 2014 | Differential expression of secretoglobins in normal ovary and in ovarian carcinoma--overexpression of mammaglobin-1 is linked to tumor progression. | 5 |
| 24706379 | 2014 | The clinical utility of circulating tumor cells in breast cancer patients: detection by a quantitative assay of h-MAM gene expression. | 0 |
| 23332923 | 2013 | Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas. | 23 |
| 23807163 | 2013 | Mammaglobin B (SCGB2A1) is a novel tumour antigen highly differentially expressed in all major histological types of ovarian cancer: implications for ovarian cancer immunotherapy. | 18 |
| 23332923 | 2013 | Expression of mammaglobin and gross cystic disease fluid protein-15 in breast carcinomas. | 23 |
Citation
Dessen P
SCGB2A1 (secretoglobin family 2A member 1)
Atlas Genet Cytogenet Oncol Haematol. 2003-08-01
Online version: http://atlasgeneticsoncology.org/gene/42212/scgb2a1
